{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:09:23Z","timestamp":1792300163295,"version":"4.4.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.rmed.2018.02.020","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T23:13:58Z","timestamp":1519773238000},"page":"191-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Pulmonary hypertension in chronic hemolytic anemias: Pathophysiology and treatment"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-2872","authenticated-orcid":false,"given":"Alexandra","family":"Haw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I.","family":"Palevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.rmed.2018.02.020_bib1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"25_S","key":"10.1016\/j.rmed.2018.02.020_bib2","doi-asserted-by":"crossref","first-page":"D1","DOI":"10.1016\/j.jacc.2013.10.030","article-title":"The Fifth World Symposium on pulmonary hypertension","volume":"62","author":"Gali\u00e8","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.rmed.2018.02.020_bib3","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Gali\u00e8","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmed.2018.02.020_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/156652408786241447","article-title":"Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders","volume":"8","author":"Morris","year":"2008","journal-title":"Curr. Mol. Med."},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2008.1.177","article-title":"Mechanisms of vasculopathy in sickle cell disease and thalassemia","volume":"2008","author":"Morris","year":"2008","journal-title":"Hematology"},{"issue":"24","key":"10.1016\/j.rmed.2018.02.020_bib6","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2014-03-563874","article-title":"Erythroid DAMPs drive inflammation in SCD","volume":"123","author":"Gladwin","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.V99.1.36","article-title":"The hypercoagulable state in thalassemia","volume":"99","author":"Eldor","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.rmed.2018.02.020_bib8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1164\/rccm.200610-1498OC","article-title":"Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension","volume":"175","author":"Anthi","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.rmed.2018.02.020_bib9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.rmed.2018.02.020_bib10","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1161\/ATVBAHA.115.306088","article-title":"Adventitia and perivascular cells","volume":"35","author":"Majesky","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.rmed.2018.02.020_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S2213-2600(13)70078-X","article-title":"Pulmonary hypertension in \u03b2 thalassaemia","volume":"1","author":"Anthi","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1183\/09031936.00087212","article-title":"Cellular microparticles in the pathogenesis of pulmonary hypertension","volume":"42","author":"Amabile","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2018.02.020_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1513\/AnnalsATS.201512-826FR","article-title":"Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension","volume":"13","author":"Kimmig","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"7","key":"10.1016\/j.rmed.2018.02.020_bib15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00277-014-2037-9","article-title":"Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy","volume":"93","author":"Singer","year":"2014","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.rmed.2018.02.020_bib16","first-page":"382","article-title":"An evidence-based approach to screening and diagnosis of pulmonary hypertension","volume":"31","author":"Haddad","year":"2015","journal-title":"Can. J. Cardiol."},{"issue":"Suppl. 1","key":"10.1016\/j.rmed.2018.02.020_bib17","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"10.1016\/j.rmed.2018.02.020_bib18","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.rmed.2018.02.020_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201401-0065ST","article-title":"An official American thoracic society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease","volume":"189","author":"Klings","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1749-6632.2010.05643.x","article-title":"Detection of the cardiovascular complications of thalassemia by echocardiography","volume":"1202","author":"Malcolm Walker","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"10.1016\/j.rmed.2018.02.020_bib21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1005565","article-title":"A hemodynamic study of pulmonary hypertension in sickle cell disease","volume":"365","author":"Parent","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00134410","article-title":"Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease","volume":"39","author":"Fonseca","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2012.10.009","article-title":"Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis","volume":"26","author":"Bossone","year":"2013","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"6","key":"10.1016\/j.rmed.2018.02.020_bib25","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2012.09166.x","article-title":"Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function","volume":"158","author":"Hill","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.rmed.2018.02.020_bib27","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood.V106.11.1046.1046","article-title":"Nitric oxide consumption and pulmonary hypertension in patients with paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Hill","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.rmed.2018.02.020_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2141.2011.08777.x","article-title":"NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease","volume":"154","author":"Machado","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jama.296.3.310","article-title":"N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease","volume":"296","author":"Machado","year":"2006","journal-title":"J. Am. Med. Assoc."},{"issue":"9757","key":"10.1016\/j.rmed.2018.02.020_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.rmed.2018.02.020_bib31","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7526","key":"10.1016\/j.rmed.2018.02.020_bib32","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/515S2a","article-title":"Epidemiology: a moving target","volume":"515","author":"Pleasants","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.rmed.2018.02.020_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med."},{"issue":"9314","key":"10.1016\/j.rmed.2018.02.020_bib34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(02)08273-9","article-title":"Protective effects of the sickle cell gene against malaria morbidity and mortality","volume":"359","author":"Aidoo","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rmed.2018.02.020_bib35","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2002-03-0948","article-title":"Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival","volume":"101","author":"Castro","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.2006.06110.x","article-title":"Pulmonary hypertension in patients with sickle cell disease: a longitudinal study","volume":"134","author":"Ataga","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.rmed.2018.02.020_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by Expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"J. Am. Med. Assoc."},{"issue":"8","key":"10.1016\/j.rmed.2018.02.020_bib38","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/rccm.201207-1222OC","article-title":"Hemodynamic predictors of mortality in adults with sickle cell disease","volume":"187","author":"Mehari","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2018.02.020_bib39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary pypertension: results from A National prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.rmed.2018.02.020_bib40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2014-12-614370","article-title":"Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease","volume":"126","author":"Detterich","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.rmed.2018.02.020_bib41","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.201105-0783OC","article-title":"Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease","volume":"184","author":"Dessap","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11239-013-0895-y","article-title":"Sickle cell disease and venous thromboembolism: what the anticoagulation Expert needs to know","volume":"35","author":"Naik","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"issue":"9","key":"10.1016\/j.rmed.2018.02.020_bib43","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1513\/AnnalsATS.201408-405CME","article-title":"Pulmonary hypertension in sickle cell disease","volume":"11","author":"Hayes","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ejcts\/ezw062","article-title":"Pulmonary endarterectomy is effective and safe in patients with haemoglobinopathies and abnormal red blood cells: the papworth experience","volume":"50","author":"Mahesh","year":"2016","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"issue":"143","key":"10.1016\/j.rmed.2018.02.020_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0119-2016","article-title":"Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension","volume":"26","author":"Lang","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.CIR.103.1.10","article-title":"Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension","volume":"103","author":"Feinstein","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.rmed.2018.02.020_bib47","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCINTERVENTIONS.112.971077","article-title":"Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension","volume":"5","author":"Mizoguchi","year":"2012","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"5","key":"10.1016\/j.rmed.2018.02.020_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.hjc.2016.11.006","article-title":"A case of balloon pulmonary angioplasty as a palliative therapy in chronic thromboembolic pulmonary hypertension","volume":"57","author":"Sianos","year":"2016","journal-title":"Hellenic J. Cardiol."},{"issue":"2","key":"10.1016\/j.rmed.2018.02.020_bib49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/ajrccm.160.2.9808109","article-title":"Long-term outcome after pulmonary thromboendarterectomy","volume":"160","author":"Archibald","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2018.02.020_bib50","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.rmed.2018.02.020_bib51","doi-asserted-by":"crossref","first-page":"L314","DOI":"10.1152\/ajplung.00252.2014","article-title":"Vasculopathy and pulmonary hypertension in sickle cell disease","volume":"308","author":"Potoka","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"20","key":"10.1016\/j.rmed.2018.02.020_bib52","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib53","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/01.ju.0000081053.97792.da","article-title":"Tadalafil has No detrimental effect on human spermatogenesis or reproductive hormones","volume":"170","author":"Hellstrom","year":"2003","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib54","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2010.08097.x","article-title":"Exercise capacity and hemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies","volume":"149","author":"Barst","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.rmed.2018.02.020_bib55","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.chest.2015.11.016","article-title":"Chronic pulmonary complications of sickle cell disease","volume":"149","author":"Mehari","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2018.02.020_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bpobgyn.2016.10.013","article-title":"New trend in the epidemiology of thalassaemia","volume":"39","author":"Li","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.rmed.2018.02.020_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/nyas.13037","article-title":"Pulmonary hypertension associated with thalassemia syndromes","volume":"1368","author":"Fraidenburg","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.rmed.2018.02.020_bib58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/ejh.12261","article-title":"Effect of genotype on pulmonary hypertension risk in patients with thalassemia","volume":"92","author":"Teawtrakul","year":"2014","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib59","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000347177","article-title":"Pulmonary hypertension risk in patients with hemoglobin H disease: low incidence and absence of correlation with splenectomy","volume":"130","author":"Yin","year":"2013","journal-title":"Acta Haematol."},{"issue":"5","key":"10.1016\/j.rmed.2018.02.020_bib60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0609.2004.00304.x","article-title":"Cardiac status in well-treated patients with thalassemia major","volume":"73","author":"Aessopos","year":"2004","journal-title":"Eur. J. Haematol."},{"issue":"10","key":"10.1016\/j.rmed.2018.02.020_bib61","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"Taher","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.rmed.2018.02.020_bib62","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3324\/haematol.2012.082065","article-title":"Sildenafil therapy in thalassemia patients with Doppler-Defined risk of pulmonary hypertension","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.rmed.2018.02.020_bib63","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3324\/haematol.2013.095810","article-title":"Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up","volume":"99","author":"Derchi","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.rmed.2018.02.020_bib64","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1182\/blood.V108.11.985.985","article-title":"The incidence and prevalence of paroxysmal nocturnal hemoglobinuria (PNH) and survival of patients in Yorkshire","volume":"108","author":"Hill","year":"2015","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.rmed.2018.02.020_bib65","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria","volume":"333","author":"Hillmen","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.rmed.2018.02.020_bib66","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ejh.12520","article-title":"Update on paroxysmal nocturnal haemoglobinuria: on the long way to understand the principles of the disease","volume":"94","author":"Schubert","year":"2015","journal-title":"Eur. J. Haematol."},{"issue":"13","key":"10.1016\/j.rmed.2018.02.020_bib67","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.2007.06554.x","article-title":"Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria","volume":"137","author":"Hill","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.rmed.2018.02.020_bib69","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2010-02-268193","article-title":"Pulmonary hypertension and nitric oxide depletion in sickle cell disease","volume":"116","author":"Bunn","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.rmed.2018.02.020_bib70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2141.2004.04992.x","article-title":"Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays","volume":"126","author":"Moyo","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib71","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","article-title":"Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria","volume":"149","author":"Hill","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.rmed.2018.02.020_bib72","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.rmed.2018.02.020_bib73","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1182\/blood-2009-04-210112","article-title":"Vascular complications after splenectomy for hematologic disorders","volume":"114","author":"Crary","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.rmed.2018.02.020_bib74","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V97.11.3411","article-title":"Cardiac involvement in thalassemia intermedia: a multicenter study","volume":"97","author":"Aessopos","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.rmed.2018.02.020_bib75","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7326\/0003-4819-130-6-199903160-00014","article-title":"Pulmonary hypertension after splenectomy?","volume":"130","author":"Hoeper","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.rmed.2018.02.020_bib76","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/thx.2004.038083","article-title":"Splenectomy and chronic thromboembolic pulmonary hypertension","volume":"60","author":"Ja\u00efs","year":"2005","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.rmed.2018.02.020_bib77","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/thx.2005.043216","article-title":"Pulmonary hypertension after splenectomy: a consequence of loss of the splenic filter or is there something more?","volume":"60","author":"Peacock","year":"2005","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.rmed.2018.02.020_bib78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2008.07091.x","article-title":"Disorders of red cell membrane","volume":"141","author":"An","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.rmed.2018.02.020_bib79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5320\/wjr.v5.i2.69","article-title":"Post splenectomy related pulmonary hypertension","volume":"5","author":"Palkar","year":"2015","journal-title":"World J. Respirol."},{"issue":"10","key":"10.1016\/j.rmed.2018.02.020_bib80","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/hrt.2005.079970","article-title":"Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia","volume":"92","author":"Phrommintikul","year":"2006","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.rmed.2018.02.020_bib81","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/j.1538-7836.2010.04030.x","article-title":"Red cells playing as activated platelets in thalassemia intermedia","volume":"8","author":"Mannucci","year":"2010","journal-title":"J. Thromb. Haemostasis"},{"issue":"25, Supplement","key":"10.1016\/j.rmed.2018.02.020_bib82","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Gali\u00e8","year":"2013","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611118300593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611118300593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:41:29Z","timestamp":1760614889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611118300593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":82,"alternative-id":["S0954611118300593"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2018.02.020","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary hypertension in chronic hemolytic anemias: Pathophysiology and treatment","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2018.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}